RM

Ramkrishn Mandloi

Active Director Director DIN 11036964
DIN 11036964 First appointment Apr 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ramkrishn Mandloi

Data last updated:

Ramkrishn Mandloi is a Director at Almr Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11036964
Primary Designation Director
Industry Pharma
First Appointment 03 Apr 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Almr Pharmaceuticals Private Limited U47721MP2025PTC075910
Director03 Apr 20252025Active

Board colleagues of Ramkrishn Mandloi

NameDINCompanyDesignation
Lavlesh Mandloi11036963Almr Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Almr Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ramkrishn Mandloi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ramkrishn Mandloi

Ramkrishn Mandloi currently holds 1 directorship: Almr Pharmaceuticals Private Limited (Director, since 03 Apr 2025).

Ramkrishn Mandloi was first appointed on 03 Apr 2025 as Director at Almr Pharmaceuticals Private Limited.

The current boards of Ramkrishn Mandloi's companies include Lavlesh Mandloi (Almr Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available